HOME
RESEARCH
ABOUT US
CONTACT
More
We have identified that FAK is a potent target for diffuse stomach cancer and FAK is amplified in other types of cancer...
FAK degrader has the potential to overcome the drug resistance to FAK inhibitor...
Synthetic lethality strategy can kill the tumor cells with specific genomic alteration but spare the normal cells...
Developing targeted therapies for those malignancies that are insensitive to chemo treatment...